Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax
- 25 November 2008
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (47) , 18081-18087
- https://doi.org/10.1073/pnas.0808691105
Abstract
A central issue in the control of apoptosis is whether its essential mediators Bax and Bak must be restrained by Bcl-2-like prosurvival relatives to prevent their damaging mitochondria and unleashing apoptosis. The issue is particularly vexed for Bax, which is largely a cytosolic monomer in unstressed cells. To determine whether Bax regulation requires its binding by prosurvival relatives, we replaced a conserved aspartate in its BH3 interaction domain with arginine. Bax D68R functioned and behaved like wild-type Bax in localization and activation but had greatly impaired binding to the prosurvival family members. Nevertheless, Bcl-xL remained able to block apoptosis induced by Bax D68R. Whereas cells with sufficient Bcl-xL tolerated expression of Bax D68R, it provoked apoptosis when Bcl-xL was absent, downregulated, or inactivated. Moreover, Bax D68R rendered membrane bound by a C-terminal anchor mutation overwhelmed endogenous Bcl-xL and killed cells. These unexpected results suggest that engagement of Bax by its prosurvival relatives is a major barrier to its full activation. We propose that the Bcl-2-like proteins must capture the small proportion of Bax molecules with an exposed BH3 domain, probably on the mitochondrial membrane, to prevent Bax-imposed cell death, but that Bcl-xL also controls Bax by other mechanisms.Keywords
This publication has 52 references indexed in Scilit:
- Bcl-XL Inhibits Membrane Permeabilization by Competing with BaxPLoS Biology, 2008
- The BCL-2 protein family: opposing activities that mediate cell deathNature Reviews Molecular Cell Biology, 2008
- A three-helix homo-oligomerization domain containing BH3 and BH1 is responsible for the apoptotic activity of BaxGenes & Development, 2007
- The Bcl-2 apoptotic switch in cancer development and therapyOncogene, 2007
- Embedded together: The life and death consequences of interaction of the Bcl-2 family with membranesApoptosis, 2007
- Bcl-xl does not have to bind Bax to protect T cells from deathThe Journal of Experimental Medicine, 2006
- The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralizedCancer Cell, 2006
- Bax does not have to adopt its final form to drive T cell deathThe Journal of Experimental Medicine, 2006
- Auto-activation of the Apoptosis Protein Bax Increases Mitochondrial Membrane Permeability and Is Inhibited by Bcl-2Published by Elsevier ,2006
- Probing tumor phenotypes using stable and regulated synthetic microRNA precursorsNature Genetics, 2005